Trials / Recruiting
RecruitingNCT05382663
The Jordan Study for End-Stage Renal Disease Subjects
Non-Invasive Monitoring of End-Stage Renal Disease Subjects Using Alio Medical Remote Monitoring System (RMS)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- Alio, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the Alio device to blood draws.
Detailed description
Eligible subjects who have signed a consent form will be asked to wear the Alio device at specified location(s) for up to four regularly scheduled dialysis sessions. The device will be placed and worn throughout the entire session. Subjects will have blood draws that will be used to compare to device metrics. Additional vitals and monitoring may happen throughout this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Alio Device | Non-invasive device worn over vasculature. |
Timeline
- Start date
- 2022-03-21
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2022-05-19
- Last updated
- 2024-06-21
Locations
1 site across 1 country: Jordan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05382663. Inclusion in this directory is not an endorsement.